Ignatiev V G, Zatravkin S N
N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia.
N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia,
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2023 Aug;31(Special Issue 1):706-710. doi: 10.32687/0869-866X-2023-31-s1-711-716.
This series of articles analyses the drug safety policy of the Russian Federation. The first report reveals the reasons behind the government's dramatic turnaround in the pharmaceutical market and pharmaceutical industry, which emerged in 2007-2008. Based on publications, author interviews and unique protocol documents from the government archive, the logic and sequence of a new regulatory agreement between the pharmaceutical business and the Russian state are revealed.